Pharma News

NY AG Requests FDA Review Safety Labeling on Singulair

The medication already has a black box warning on it, but the AG’s office believes stricter actions should be taken.

Source link
#Requests #FDA #Review #Safety #Labeling #Singulair

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *